佛罗里达州 的 超重 临床试验
佛罗里达州 有 53 项针对 超重 的研究正在招募参与者。
佛罗里达州 的城市
- Orlando25 项研究
- Miami23 项研究
- Jacksonville19 项研究
- Hialeah10 项研究
- West Palm Beach9 项研究
- Deltona9 项研究
- St. Petersburg9 项研究
- The Villages8 项研究
- Boca Raton7 项研究
- Tampa6 项研究
- Davie6 项研究
- Ocala6 项研究
- Pembroke Pines6 项研究
- Hollywood5 项研究
- Clearwater5 项研究
- Naples4 项研究
- Cape Coral4 项研究
- Leesburg4 项研究
- Sunrise4 项研究
- Pensacola4 项研究
- Miramar4 项研究
- Coral Springs4 项研究
- Town 'n' Country3 项研究
- Doral3 项研究
- Kendall3 项研究
- Spring Hill3 项研究
- Gainesville3 项研究
官方研究文本（英文）
Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes
- AMR Clinical - Miami, Doral
- AMR Clinical - Fort Myers, Fort Myers
- AGA Clinical Trials, Hialeah
- 以及另外 6 项
招募中2 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT07685808Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Innovative Research of West Florida /ID# 281963, Clearwater
- Encore Research Group-Jacksonville Center for Clinical Research /ID# 282740, Jacksonville
- Altus Clinical Research - Lake Worth - South Congress Avenue /ID# 281979, Lake Worth
- 以及另外 8 项
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月29日 · NCT07752979A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)
- DM Clinical Research, Bradenton
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月29日 · NCT07823608Study of ALV-100 to Assess Safety, Tolerability, and PK/PD in Overweight/Obese Participants With or Without T2D
- Clinical Pharmacology of Miami, Miami
招募中1 期
18 至 65 岁 · 所有性别 · 更新于 2026年9月28日 · NCT07399678Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
- Clinical Neuroscience Solutions, Orlando
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月28日 · NCT07837973A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Excel Medical Clinical Trials, Boca Raton
- Flourish Research Acquisition, LLC dba Flourish Research - North Miami, Miami
- New Age Medical Research Corporation, Miami
- 以及另外 5 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07794579AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
- Brain Matters Research, Delray Beach
- Northeast Research Institute, Fleming Island
- Miguel Rebollar PA, Hialeah
- 以及另外 5 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07720271A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Encore Medical Research LLC, Hollywood
- NextPhase Research, Hollywood
- Jacksonville Ctr Clin Res, Jacksonville
- 以及另外 7 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07668414A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Nature Coast Clinical Research, Crystal River
- West Coast Eye Institute, Lecanto
- South Broward Research, Miramar
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月28日 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Jacksonville
- Research Site, Jacksonville
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月25日 · NCT07776509A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- William A. Shands Hospital at the University of Florida, Gainesville
- Florida Hospital- Center for Pediatric Research, Orlando
- Nemours Children's Health, Orlando
- 以及另外 1 项
招募中3 期
6 至 17 岁 · 所有性别 · 更新于 2026年9月24日 · NCT06672549Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- 以及另外 3 项
招募中3 期
18 至 70 岁 · 所有性别 · 更新于 2026年9月24日 · NCT06937099Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Research Associates of South Florida - Miami - Southwest 8th Street, Miami
- Gastro Health Research - Miami, Miami
- Orlando Health, Orlando
- 以及另外 3 项
招募中3 期
18 至 70 岁 · 所有性别 · 更新于 2026年9月24日 · NCT06937086A Study of Tirzepatide (LY3298176) in Participants With Type 1 Diabetes Mellitus and Overweight or Obesity
- Clinical Pharmacology of Miami, Miami
招募中1 期
18 至 70 岁 · 所有性别 · 更新于 2026年9月23日 · NCT07803744A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- 以及另外 2 项
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月22日 · NCT07589608A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- JEM Research Institute, Atlantis
- AMR Clinical, Doral
- Northeast Research Institute (NERI), Fleming Island
- 以及另外 4 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07392190A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Miami, LLC, Miami
- PharmaDev Clinical Research Institute, LLC, Miami
- Emerald Coast Neurology - Airport Boulevard, Pensacola
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07369011A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Coral Gables
- Research Site, Fleming Island
- Research Site, Fort Lauderdale
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07784270Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
- Westside Center for Clinical Research, Jacksonville
- Care Access - St. Petersburg, St. Petersburg
- Conquest Research, Winter Park
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07353931A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- JEM Research Institute, Atlantis
- BioMed Research & Medical Center, Miami
- Adult Medicine of Lake County, Inc., Mt. Dora
- 以及另外 3 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07321886Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Excel Medical Clinical Trials, Boca Raton
- Velocity Clinical Research - New Smyrna Beach, Edgewater
- Alliance for Multispecialty Research - Fort Myers, Fort Myers
- 以及另外 20 项
招募中3 期
45 至 99 岁 · 所有性别 · 更新于 2026年9月22日 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Arrow Clinical Trials, Daytona Beach
- Care Access - Delray Beach, Delray Beach
- Fleming Island Center for Clinical Research, Fleming Island
- 以及另外 7 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月22日 · NCT07282600A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Boca Raton
- AURORA-1 Clinical Site, Daytona Beach
- AURORA-1 Clinical Site, Jacksonville
- 以及另外 6 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Boca Raton
- AURORA-2 Clinical Site, Daytona Beach
- AURORA-2 Clinical Site, Jacksonville
- 以及另外 6 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月16日 · NCT07743450Feasibility and Acceptability of a Pediatric Referral to Summer Day Camps to Treat Obesity in Children From Low-Income Households
- University of Central Florida, Orlando
招募中
5 至 11 岁 · 所有性别 · 更新于 2026年9月14日 · NCT07464015A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Tampa Bay Medical Research, Inc., Clearwater
- Center for Diabetes, Obesity and Metabolism Inc, Pembroke Pines
- Progressive Medical Research, Port Orange
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月14日 · NCT07351058A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
- Renstar Medical Research, Ocala
- Oviedo Medical Research, Oviedo
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月14日 · NCT06897475A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Clearwater
- ACCOMPLISH-2 Research Site, Fort Myers
- ACCOMPLISH-2 Research Site, Jacksonville
- 以及另外 5 项
招募中3 期欢迎健康志愿者
18 至 79 岁 · 所有性别 · 更新于 2026年9月11日 · NCT07654374AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- PharmaDev Clinical Research Institute LLC, Miami
- Essence MD Research, Naples
- Renstar Medical Research, Ocala
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月11日 · NCT07571005AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea
- DM Clinical, Bradenton
- Essence MD Research, Naples
- Palm Beach Research Center, West Palm Beach
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT07571109Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
- ERG Holding Company, LLC / Evolution Research Group, LLC, Delray Beach
- ERG Holding Company, LLC / Evolution Research Group, LLC, Fort Myers
- Jedidiah Clinical Research, Tampa
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月9日 · NCT07770841A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
- Precision Clinical Research, Sunrise
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月8日 · NCT07215559A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- New Horizon Research Center, Miami
- Indago Research & Health Center, Inc, Miami Lakes
- Suncoast Clinical Research, Inc., New Port Richey
- 以及另外 2 项
招募中2 期
18 至 75 岁 · 所有性别 · 更新于 2026年9月8日 · NCT06143956A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- NeoClinical Research, Hialeah
- Skin Care Research, Hollywood
- Encore Medical Research, Hollywood
- 以及另外 2 项
招募中4 期
18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT06857942AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
- Northeast Research Institute, Fleming Island
- Jacksonville Ctr Clin Res, Jacksonville
- Florida Institute for Clinical Research, LLC, Orlando
- 以及另外 1 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月4日 · NCT07533175Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Jupiter
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT07284875Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
- Optimus U Corporation, Miami
- San Marcus Research Clinic Inc, Miami Lakes
- Indago Research and Health Center, Miami Lakes
- 以及另外 3 项
招募中3 期
18 至 99 岁 · 所有性别 · 更新于 2026年9月3日 · NCT07684144Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Bradenton
- Kailera Clinical Site, Hollywood
- Kailera Clinical Site, Jupiter
- 以及另外 6 项
招募中3 期
18 岁及以上 · 所有性别 · 更新于 2026年9月3日 · NCT07284901Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
- Jacksonville Center for Clinical Research, Jacksonville
- Clinical Neuroscience Solutions - Jacksonville, Jacksonville
- South Florida Wellness and Clinical Research Institute, Margate
- 以及另外 8 项
招募中3 期
18 至 99 岁 · 所有性别 · 更新于 2026年9月3日 · NCT07684235A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Encore Medical Research LLC, Hollywood
- Jacksonville Ctr for Clin Res, Jacksonville
- Encore Medical Research of Weston, Weston
招募中3 期
8 至 18 岁 · 所有性别 · 更新于 2026年8月31日 · NCT07253285数据来自 ClinicalTrials.gov，检索日期：2026年9月30日。每项研究自行设定入选标准，由研究团队决定谁能参与。